Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis-Reference-Cited by-同舟云学术

Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis

Published:2006-07-19 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Lawson Maureen M¹,Thomas Adrian G²,Akobeng Anthony K³

Affiliation:

1. Central Manchester and Manchester Children's University Hospitals; Department of Paediatric Gastroenterology; Booth Hall Children's Hospital Charlestown Road, Blakley Manchester UK M9 7AA

2. Booth Hall Childrens Hospital; Charlestown Road Blackley Manchester UK M9 7AA

3. Royal Manchester Children's Hospital; Oxford Road Manchester UK M13 9WL

Publisher

Wiley

Subject

Pharmacology (medical)

Reference52 articles.

1. Infliximab in the treatment of steroid-dependent ulcerative colitis;Armuzzi;Eur Rev Med Pharmacol Sci,2004

2. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study;Jarnerot;Gastroenterology,2005

3. Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study;Ochsenkuhn;Eur J Gastroenterol Hepatol,2004

4. Infliximab in moderately severe glucocorticoid resistent ulcerative colitis: a randomised controlled trial;Probert;Gut,2003

5. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuing or stopping 5‐aminosalicylates in patients with inflammatory bowel disease on anti‐TNF therapy: A nationwide population‐based study;Alimentary Pharmacology & Therapeutics;2024-06-12

2. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

3. Inflammatory responses and barrier disruption in the trachea of chicks following Mycoplasma gallisepticum infection: a focus on the TNF-α-NF-κB/MLCK pathway;Veterinary Research;2024-01-15

4. Building a fatigue research collaborative: A scientometrics, topic and gap analysis;F1000Research;2023-11-29

5. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009;Zeitschrift für Gastroenterologie;2023-08